Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.9006
Delayed Data
As of Jun 28
 +0.0516 / +6.08%
Today’s Change
0.70
Today|||52-Week Range
19.80
-79.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues3.6M3.3M3.1M3.5M
 
 
 
 
 
Cost of Goods Sold1.7M1.7M1.6M1.6M
 
 
 
 
 
Depreciation And Amortization1.1M1.1M993.0K972.0K
 
 
 
 
 
 
Operating ExpensesGross Income800.0K500.0K486.0K886.0K
 
 
 
 
 
General Expenses3.7M4.8M4.4M1.5M
 
 
 
 
 
Research And Development357.0K659.0K308.0K306.0K
 
 
 
 
 
Total Operating Expenses6.5M7.6M7.1M4.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.9M-4.3M-3.9M-578.0K
 
 
 
 
 
Extraordinary Credit0.001.2M10.7M5.8M
 
 
 
 
Extraordinary Charge0.00-3.4M0.00-3.0M
 
 
 
Interest Expense On Debt858.0K539.0K544.0K254.0K
 
 
 
 
 
Other Expenses3.0K4.0K0.00-36.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.7M-7.0M6.2M1.9M
 
 
 
 
 
Income Taxes-236.0K-173.0K-108.0K-3.0K
 
 
 
 
 
Discontinued Operations1.2M-297.0K-23.0K556.0K
 
 
 
 
 
Net Income-2.3M-7.5M6.3M2.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.8M1.8M1.9M4.3M
 
 
 
 
 
Shares To Calculate EPS Diluted1.8M1.8M1.9M4.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.30-$4.10$3.24$0.55
 
 
 
 
 
EPS Diluted-$1.30-$4.13$3.24$0.55